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Abstract: The small and large delta antigens (S-HDAg and L-HDAg, respectively) represent two forms of the only 
protein encoded by the hepatitis delta virus (HDV) RNA genome. Consequently, HDV relies, at a large extent, on the host 
cell machinery for replication and transcription. Until now, only a limited number of cellular proteins were identified as S-
HDAg or L-HDAg partners being involved in the modulation of the virus life cycle. In an attempt to identify cellular S-
HDAg-binding proteins we made use of a yeast two-hybrid approach to screen a human liver cDNA library. We were able 
to identify HuR, a ubiquitously expressed protein involved in RNA stabilization, as an S-HDAg partner both in vitro and 
in vivo. HuR was found to be overexpressed and colocalize with HDAg in human hepatoma cells. siRNA knockdown of 
HuR mRNA resulted in inhibition of S-HDAg and L-HDAg expression. 
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INTRODUCTION 
 Hepatitis delta virus (HDV) coinfects or superinfects 
human hepatocytes already infected with hepatitis B virus 
(HBV) resulting in increased liver damage and risk of 
cirrhosis and fulminant disease [1]. The HDV outer envelope 
consists of HBV surface antigens (HBsAg) which are 
necessary for propagation of infection [2-4], and thus HDV 
is considered to be a HBV satellite virus. 
 The HDV genome consists of a single-stranded, circular 
RNA molecule of about 1.7 kilobases (kb) which bears about 
70% of internal base-pairing and folds into a rod-like 
structure similar to plant viroids. The genome contains a 
single ORF from which two forms of the same protein, the 
small and large delta antigens (S-HDAg and L-HDAg, 
respectively), are derived by an RNA editing mechanism 
catalyzed by cellular adenosine deaminase ADAR1 [5]. As a 
consequence, an amber stop codon UAG is transformed into 
a tryptophan codon UGG extending the ORF by additional 
19 aminoacids. Thus, both forms of HDAg share a number 
of specific domains: a bipartide RNA binding domain [6], an 
oligomerization domain [7] and a nuclear localization signal 
[8]. Additionally, L-HDAg was shown to be isoprenylated at 
a cysteine residue located four aminoacids from the C-
terminus [9]. Despite sequence similarities, different 
functions have been assigned to these two proteins: S-HDAg 
is required for nuclear import of HDV RNPs and synthesis of 
HDV RNA [10], whereas L-HDAg represses in trans HDV 
replication and is essential for virion assembly, through 
interaction between the C-terminal and HBsAg [11]. 
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 HDV RNA replication involves the redirection of at least 
cellular DNA-dependent RNA polymerase II. It is believed 
that HDV RNA synthesis occurs through a rolling-circle 
mechanism resulting in the formation of multimeric 
antigenomes which are self-cleaved and ligated at precise 
monomeric intervals. These antigenomes serve as templates 
for subsequent synthesis of genomic RNA molecules by a 
similar mechanism. 
 HDV is the smallest human pathogen identified so far 
being highly dependent on host cell factors to accomplish the 
replication cycle. Several cellular proteins were already 
reported to bind to HDV RNA and antigens. Some were 
already shown to play an important role in the virus life 
cycle but the precise function of a significant number 
remains elusive (reviewed in [12]). These proteins include 
ADAR1 which binds to antigenomic RNA during editing 
[13] and RNA polymerase II which was shown to interact 
with HDV RNA [14]. Additionally, transcription factors and 
proteins involved in RNA metabolism, namely the TATA-
binding protein [15], the zinc finger transcription factor YY1 
[16], and the polyrimidine tract-binding protein associated 
splicing factor (PSF; [17]), were also reported to bind to the 
virus RNA and antigens. Nucleolar proteins, such as 
nucleolin [18] and B23 were also shown to bind to S-HDAg 
to form a large complex which was proposed to enhance 
HDV replication [19]. Finally, using a yeast two hybrid 
approach it was possible to identify the nuclear export 
signal-interacting protein (NESI) as cellular counterpart of 
L-HDAg being essential to promote nuclear export and 
assembly of HDV genomic RNA [20]. Moreover, proteomic 
approaches were used to identify changes in cellular protein 
expression caused by the presence of HDV components [21, 
22] and a study making use of immunoprecipitation followed 
by mass spectrometry analysis lead to identification of more 
than 100 proteins that may interact with S-HDAg [23]. 
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 Despite the increasing number of cellular factors 
described as HDV RNA or antigens partners, the role of 
most of these interactions in HDV replication were not 
elucidated, and many steps of the virus life cycle remain 
unclear. Furthermore, given the simplicity of the virus and 
the limited number of host factors found to play a role in its 
replication, it is highly probable that still a considerable 
number remains to be uncovered. 
 In an attempt to identify new cellular partners of S-
HDAg, in this work we screened a human liver cDNA 
library using a yeast two-hybrid approach. The HuR protein, 
a member of the ELAV (embryonic lethal abnormal vision) 
family of RNA-binding proteins, was found to specifically 
interact with S-HDAg in this system. 
 HuR is a nucleocytoplasmic shuttling protein [24] 
ubiquitously expressed in proliferating cells, and was 
previously reported to bind to AU-rich elements (AREs) of 
mRNAs affecting their stabilization and expression 
(reviewed in [25]). This ability enables HuR to play a variety 
of biological roles and to be involved in different cellular 
mechanisms including apoptosis [26, 27], oncogenesis [28], 
and cellular response to stress [29]. HuR was also found to 
directly interact with the HIV-1 reverse transcriptase to 
modulate reverse transcription by a still unknown 
mechanism [30], to bind to 3’ ends of hepatitis C virus 
(HCV) RNA [31] and to the 3’ untranslated region of human 
papillomavirus RNA [32]. Additionally, it was recently 
reported that HuR is involved in the translational control of 
HIV-1 and HCV IRES (internal ribosome entry site) 
elements [33]. The authors also showed that regulation of 
IRES elements seems not to involve a direct interaction of 
HuR with the RNA. 
 Here, we report that HuR and S-HDAg interact both in 
vivo and in vitro, and colocalize in human liver cells. 
Furthermore, HuR was found to be overexpressed in cells 
expressing HDV RNPs. Finally, HuR silencing with specific 
siRNAs lead to a decrease in both S-HDAg and L-HDAg 
expression. The obtained results suggest that HuR plays an 
important role in HDV replication. 
MATERIALS AND METHODOLOGY 
Yeast Two-Hybrid Screening 
 The yeast two-hybrid screening was performed in 
Saccharomyces cerevisiae using the Matchmaker system 
(BD Biosciences). 
 The gene coding for the S-HDAg was PCR amplified 
from pSVL-AgS [11], using the primers 5’-ttatcaattgatgag 
ccggtccgagtcg-3 (forward) and 5´-ttatgtcgacctatggaaatccct 
ggtttccc-3’ (reverse). The resulting fragment was cleaved 
(MunI/BamHI) and inserted into pAS2-1 vector (BD 
Biosciences) in the local EcoRI/BamHI, to obtain the 
plasmid pAS2-1/S-HDAg. This plasmid contains the S-
HDAg entire gene fused to the GAL4 DNA binding domain 
(BD) and was used as bait to screen a human liver cDNA 
library representing fusions of the GAL4 activation domain 
(AD) pretransformed into the Y187 yeast strain. 
 Screening of the library was performed according to 
manufacturer’s instructions. To reduce the false positives 
after selection, the selected yeast colonies were transferred to 
Trp, Leu, His and Ade dropout nutritional selection media 
and assayed for MEL1 activity. 
 Prey plasmids encoding human liver proteins that 
interacted with S-HDAg in the MEL1 positive yeast clones 
were isolated after transformation in E. coli DH5 . AD 
plasmids were recovered from positive yeast clones and 
retransformed into native AH109 yeast with the bait plasmid 
pAS2-1/S-HDAg to retest the interactions. Finally, the 
recovered plasmids were subjected to DNA sequencing. 
Production and Purification of Recombinant Proteins 
 The bacterial expression vectors pGEX-6P-2 (GE 
HealthCare) and pET28c (Novagen) were used to produce 
GST or His-tagged fusion proteins, respectively. 
 The fusion vector for expression of GST/S-HDAg 
(pGEX-6P-2/S-HDAg) was constructed by digesting plasmid 
pEGFP-C1-HDAg (Tavanez et al. 2002) using the restrict-
ions enzymes BglII and SalI followed by insertion of the 
obtained S-HDAg cDNA fragment into the XhoI/BamHI 
cloning sites of pGEX-6P-2. To construct the plasmid 
pET28c/HuR for expression of His6/HuR fusion proteins, the 
HuR cDNA cloned in pCMV_SPORT6 (Image clone # 
2901220) was amplified using the following primers: 5’-
ttatcaattgccatgtctaatggttatgaagaccacatgg-3’ (forward) and 5’- 
ttatgtcgaccgagttatttgtgggacttgttgg-3´ (reverse). The resulting 
fragment was cleaved with MunI and SalI and cloned into 
pET28c, in the EcoRI/SalI sites. 
 Resulting recombinant plasmids pGEX-6P-2-HDAg and 
pET28c/HuR were used to transform E. coli BL21 and E. 
coli BL21-CodonPlus-(DE3)-RP competent cells 
(Stratagene), respectively. The expression of both GST/S-
HDAg and His6/HuR were induced with 1 mM isopropyl-B-
D-thiogalactopyranoside (IPTG) at 37º C for 2 h. Cells were 
then harvested by centrifugation, washed with phosphate-
buffered saline (PBS) and resuspended in PBS containing 
0.1mg/mL lysozyme (Sigma). After three freeze-thaw cycles 
the obtained samples were treated with DNase I (Roche). 
 For purification of recombinant S-HDAg, protein extracts 
were loaded onto a GSTrap FF 1mL column (GE 
Healthcare). After washing, the GST-tag was removed by 
digesting with the PreScission protease (GE Healthcare) 
according to the instructions of the manufacturer. Finally, the 
eluted protein was dialyzed against PBS and quantified using 
a Bradford assay based kit (BioRad). 
Cell Culture 
 Two different cell lines were used in this study. The 
human hepatocellular carcinoma cell line (Huh7) and the 
corresponding HDV cDNA stably transfected cell line 
(Huh7-D12), which constitutively expresses HDV ribonuc-
leoproteins [35]. Cells were grown as monolayers in RPMI 
1640 medium (Sigma) supplemented with 10% fetal bovine 
serum (Invitrogen). Cells were cultured at 37ºC in a 
humidified atmosphere containing 5% CO2. 
Blot Overlay 
 Blot overlay assays were performed essentilally as 
described [36]. Briefly, increasing amounts of bacterial 
extracts containing His6/HuR recombinant protein were 
separated on 12% SDS/PAGE gels. The proteins were 
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subsequently transferred to a nitrocellulose membrane that 
was then overlaid with 40 g purified recombinant S-HDAg 
protein. After washing, bound S-HDAg was detected by 
immunoblot using a rabbit polyclonal anti-S-HDAg antibody 
(B3; [37]) followed by incubation with a secondary anti-
rabbit IgG antibody conjugated with peroxidise (BioRad). 
Membrane development was achieved using an enhanced 
chemiluminescence system (ECL; GE Healthcare) according 
to the specifications of the manufacturer. 
Coimmunoprecipitation 
 For coimmunoprecipitation, Huh7 or Huh7-D12 cells 
were collected in lysis buffer [50mM Tris-HCl (pH 7.5), 
150mM NaCl, 1% Nonidet P-40 and 10% glycerol] 
supplemented with complete protease inhibitor cocktail 
(ROCHE). Cell extracts were precleared with protein G 
Dynabeads (Invitrogen) and incubated for 2 h at 4ºC with a 
polyclonal rabbit anti-HDAg antibody (B3; [37]). Protein G 
Dynabeads (Invitrogen) were then added and 
immunoprecipitates were washed three times with PBS. 
Antigen-antibody complexes were recovered by boiling in 
SDS sample buffer and analyzed by western blot as 
described below. 
Western Blot 
 To prepare protein samples for western blot, Huh7 or 
Huh7-D12 cells were first harvested, washed twice with 
PBS, and pelleted by centrifugation. The cell pellet was re-
suspended in SDS sample buffer and boiled. Western blot 
was performed as previously described [38]. 
 Protein samples, either recombinant or immunoprecipita-
ted proteins, were separated by SDS-PAGE on 12% 
polyacrilamide gels and electroblotted onto nitrocellulose 
membranes (Schleicher & Schuell). Blots were then 
incubated for 1 h with one of the following primary 
antibodies: mouse monoclonal antibody against HuR (Santa 
Cruz Biotechnology), rabbit polyclonal anti-HDAg antibody 
B3 [37], and mouse anti-His-tag monoclonal antibody 
(Sigma-Aldrich). When appropriate the control house-
keeping protein clathrin was also detected using an anti-
clathrin antibody (Santa Cruz Biotechnology), and used to 
normalize for the amount of each selected protein. After 
washing with PBS containing 0.1% Tween 20 and 2% low 
fat milk powder, blots were further incubated with 
appropriate secondary antibodies conjugated with horsera-
dish peroxidase (BioRad). Membrane development was 
performed using an enhanced chemiluminescence system 
(ECL; GE Healthcare). 
 When needed the density of the bands was quantified 
using the ImageJ software (http://rbs.info.nih.gov/ij/). 
Immunofluorescence and In Situ Hybridization 
 Indirect imunofluorescence and in situ hybridization 
were essentially performed as earlier described [38]. In brief, 
for immunofluorescence, cells grown on coverslips were 
rinsed briefly in PBS, fixed with 3.7% formaldehyde and 
permeabilized with 0.5% Triton X-100 in PBS, for 10 min, 
at room temperature. Cells were then rinsed with PBS 
containing 0.05% Tween 20 (PBS-T) and incubated with 
primary antibodies (polyclonal rabbit anti-HDAg serum B3 
and/or mouse monoclonal against HuR; Santa Cruz 
Biotechnology). After washing with PBS-T, cells were 
incubated with appropriate secondary antibodies conjugated 
to either FITC or Texas Red (Jackson Immunoresearch 
Laboratories). Finally, the coverslips were mounted in 
Vectashield (Vector Laboratories, UK). 
 In situ hybridization was performed using a digoxigenin-
11-dUTP (Roche) nick translated plasmid pSVL(D3) [39] as 
probe. This plasmid contains a trimer of full-length genomic 
HDV cDNA cloned in pSVL (GE Healthcare). After fixation 
and permeabilization, as described above for immunofluore-
scence, cells were sequentially treated with 70% formamide 
at 73ºC followed by incubation with 50% formamide at 
73ºC, for 5 min, and finally subjected to hybridization. After 
hybridization, digoxigenin detection was performed using a 
monoclonal anti-digoxigenin antibody conjugated with FITC 
(Roche) followed by incubation with a secondary anti-FITC 
antibody conjugated with Alexa-488 (Jackson Immuno 
Research Laboratories). Finally, the coverslips were moun-
ted in Vectashield (Vector Laboratories, UK). 
Confocal Microscopy and Image Analysis 
 Fluorescent-labeled samples were analyzed under a Zeiss 
LSM 510 META confocal microscope. Green fluorescence 
was detected using an Argon Ion laser (488 nm) and red 
fluorescence was detected using a Helium-Neon laser (543 
nm). Calibration of the equipment was achieved using 
multicolor fluorescent beads (Molecular Probes, USA) and a 
dual-band filter which allows simultaneous visualization of 
green and red fluorescence. 
 The quantitative colocalization analysis was performed 
using the JACoP plugin (Just Another Co-localization Plug-
in; [40]) and the ImageJ software (http://rbs.info.nih.gov/ij/). 
The Mander´s overlap coefficient (OC), which expresses the 
correlation of pixel intensities in both analyzed channels was 
used for presentation of results. This coefficient ranges from 
0 to 1, where 0 indicates no overlap and 1 reflects 100% 
colocalization between both channels of the analyzed image 
[41]. 
siRNA Induced HuR Knockdown 
 To knockdown endogenous expression of HuR protein in 
Huh7 cells, we used the pSIREN-RetroQ vector (BD 
Biosciences). The oligonucleotide sequences used for 
silencing the expression of HuR were predicted using a 
bioinformatic tool (http://bioinfo.clontech.com/rnaidesigner): 
5´-gatccgaggcaattaccagtttcattcaagagatgaaactggtaattgcctctttttt 
acgcgtg 3’ (sense) and 
5´-aattcacgcgtaaaaaagaggcaattaccagtttcatctcttgaatgaaactggtaa 
ttgcctcg-3’ (antisense), where the underlined nucleotides 
denote the HuR shRNA sequence targeting HuR mRNA 
(nucleotides 484 to 492 in HuR cDNA). 
 To construct plasmids used for RNAi the 
oligonucleotides were first allowed to anneal in vitro. This 
was performed by ressuspending in TE buffer followed by 
heating to 95ºC for 30 sec and two sequential incubations at 
72º C and 37º C, both for 2 min. Finally the oligonucleotides 
were allowed to cool at room temperature to generate double 
stranded DNA (dsDNA). The obtained dsDNA was cloned 
into the EcoRI/BamHI digested pSIREN-RetroQ vector thus 
generating the pSIREN-RetroQ/HuR. To construct the 
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control vector pSIREN-RetroQ/Luc, the oligonucleotides 
provided by the manufacturer for luciferase gene silencing 
were introduced into an identical vector according to the 
corresponding instructions. 
 For transfection, the FuGENE6 transfection reagent 
(Roche) was used according to the specifications of the 
manufacturer. First 1 g plasmid pSVL(D3) was used to 
transfect Huh7 cells. After 48 hours incubation, cells were 
transfected again with plasmid pSIREN-RetroQ/HuR or the 
negative control (pSIREN-RetroQ/Luc). 24 hours post-
transfection, puromycin was added to the medium (2μg/mL) 
to select for pSIREN-RetroQ plasmids transfected cells. 
Following additional 48 hours incubation, cells were 
harvested for subsequent western blot analysis. Western 
blots were performed as described before using the following 
primary antibodies: rabbit polyclonal anti-HDAg antibody 
(B3; [37]), mouse anti-His-tag monoclonal antibody (Sigma-
Aldrich), rabbit polyclonal anti-clathrin antibody (Santa 
Cruz Biotechnology), and a mouse monoclonal antibody 
against HuR (Santa Cruz Biotechnology). After incubation 
with appropriate anti-mouse or anti-rabbit secondary 
antibodies conjugated with horseradish peroxidase (GE 
Healthcare) blots were developed using an ECL system (GE 
Healthcare). 
RESULTS 
Identification of HuR Protein as a Binding Partner of S-
HDAg in a Yeast Two-Hybrid Screening 
 To identify proteins capable of interacting with S-HDAg, 
this protein was fused to the C terminus of the DNA binding 
domain of GAL4 (GAL4BD) and used as bait in a yeast two 
hybrid screen of a human liver cDNA library containing 
approximately 1 x10
8
 clones. A total of 112 positive clones 
were obtained. After sequence analysis and database search, 
one of the positive clones was found to bear a plasmid 
containing a cDNA fragment encoding about 96% of the 
entire open reading frame (ORF) of the ELAV-like 1 
(ELAVL1) protein, in frame with the GAL4 activation 
domain (Fig. 1A). 
 Human ELAVL1 (GenBank NP_001419), also known as 
HuR (Hu antigen R), is a 326 amino acid protein and has 
been described as a RNA binding protein, comprising three 
RNA binding domains (RBDs), also known as RNA 
recognition motifs (RRMs). The sequence identified in the 
yeast two- hybrid screening comprises amino acids 12 to 326 
of the full length HuR (Fig. 1A), including the three RRMs. 
 The HuR protein was previously reported to participate 
in post-transcriptional regulation processes and has also been 
proposed to be an important player in the replication cycle of 
several viruses, including HIV-1, HCV, and HVS [30, 31, 
42]. Thus, it is possible that this protein might also involved 
in HDV replication. To investigate this hypothesis we first 
decided to confirm the results obtained in the yeast two-
hybrid screening. Yeast AH109 cells were cotransformed 
with the bait (pAS2-1/S-HDAg) and prey plasmids isolated 
from the positive yeast clone (pGADT7/Rec/HuR12-326), and 
the interaction between the two proteins was tested using 
three reporter genes (ADE2, HIS3, and MEL1). Yeast  
 
 
AH109 cells transformed with pAS2-1/S-HDAg or 
pGADT7-Rec/HuR12-326 alone were used as controls in these 
experiments. In contrast with the negative controls, yeast 
cells expressing both BD/S-HDAg and AD/HuR12-326 fusion 
proteins could effectively grow in minimal medium lacking 
tryptophan, leucine, histidine, and adenine (SD/-Leu/-Trp/-
Hist/-Ade), and displayed strong -galactosidase activity 
(Fig. 1B). These results allowed confirming the interaction 
of S-HDAg and HuR in the yeast two-hybrid system. 
 
Fig. (1). HuR interacts with S-HDAg in a yeast two-hybrid 
assay. (A) Schematic representation of HuR and the AD fusion 
protein expressed in yeast positive clone (AD/HuR). The protein 
AD/HuR includes a truncated form of HuR, devoid of the first N-
terminal 12 aa. GAL-AD represents the activation domain of the 
GAL4 transcription factor and RRMs represent the RNA 
recognition motifs in the HuR protein. (B) AH109 yeast cells were 
(co)transformed with the indicated plasmids. Interactions were 
tested by growth selection on dropout media lacking the amino 
acids Leu or Trp (SD/-Leu or SD/-Trp) to select for pGADT7/Rec 
or pAS2-1 plasmid constructs, respectively. Activation of reporter 
genes was tested on plates lacking Leu, Trp, Hist and Ade, and 
containing X- -Gal (SD/-Trp/-Leu/-Hist/-Ade/X-a-Gal). 
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HuR and S-HDAg Interact In Vitro and In Vivo in Huh7 
Cells 
 After establishing that S-HDAg and HuR interact in the 
yeast two-hybrid system, we decided to investigate whether 
the two proteins also interact in human liver cells. We first 
tested this interaction in vitro using a blot overlay assay. The 
vector pGEX-6P-2/S-HDAg was used to produce GST/S-
HDAg fusion protein in E. coli cells. GST/S-HDAg protein 
was purified from bacterial extracts using glutathione 
sepharose columns and the GST tag was cleaved with 
PreScission Protease to obtain untagged S-HDAg. 
Purification of recombinant untagged S-HDAg was 
evaluated by western blot, and protein concentration was 
determined using a Bradford assay (data not shown). 
Expression of His6-HuR was induced in E. coli cells 
transformed with plasmid pET28c/HuR. Increasing amounts 
of the obtained protein samples were loaded onto different 
wells of a 12% SDS-PAGE gel. After separation proteins 
were transferred to a nitrocellulose membrane which was 
subsequently overlaid with 40 g of recombinant S-HDAg. 
Detection of bound S-HDAg was performed using a specific 
polyclonal antibody. The obtained results are displayed in 
Fig. (2A) showing that increasing amounts of the His6-HuR 
protein result in a proportional increase in the amounts of 
bound S-HDAg, suggesting a specific interaction between 
the two proteins. 
 The in vivo interaction of HuR with S-HDAg was further 
investigated using a coimmunoprecipitation assay and Huh7-
D12 cells. This cell line was previously reported to express 
constitutively both forms of the delta antigen and virus RNA 
[35, 38]. Since HuR is ubiquitously expressed in 
proliferating cells [43], the eventual interaction of the two 
proteins should be detectable in this system. Huh7-D12 
protein extracts were prepared and incubated with a rabbit 
polyclonal antibody against HDAg. Immunoprecipitated 
protein samples were separated by SDS-PAGE, transferred 
to a nitrocellulose membrane, and immunobloted with an 
anti-HuR antibody. Similar procedures in the absence of 
anti-HDAg antibodies or using Huh7 cells protein extracts 
were performed in these experiments as negative controls. 
As shown in Fig. (2B), in Huh7-D12 cells protein extracts 
HuR was coprecipitated together with the S-HDAg being 
consistent with an in vivo association of the two proteins in 
human liver cells. 
HuR Colocalizes with HDV Antigens and RNA in Human 
Hepatoma Cells 
 It has been previously shown that the HuR protein is 
involved in post-transcriptional modifications of RNAs and 
may modulate the replication of HIV-1, HCV, HSV, and 
HPV [30-33]. Since S-HDAg and HuR interact both in vitro 
and in vivo, it may be plausible that HuR is also involved in 
the control of some stages of the HDV replication cycle. To 
test this possibility our first approach was designed in order 
to investigate an eventual colocalization of HuR with the 
virus RNA and antigens inside the cell. This was performed 
by immunofluorescence and in situ hybridization followed 
by confocal microscopy and image analysis of Huh7-D12 
cells, which constitutively express HDV RNPs [35, 38]. 
 In accordance with previous findings [38] the delta 
antigens were found to be localized in the nucleus of Huh7-
D12 cells, with a preferential accumulation in foci (Fig. 3A). 
The HuR protein also showed a nuclear localization pattern 
and seemed to colocalize with the HDAgs (Fig. 3B, C). The 
extent of colocalization of S-HDAg and HuR was analyzed 
quantitatively by calculating the Mander´s overlap 
coefficient (OC). This coefficient gives an estimate of 
intensity-based correlation of green (HDAg) and red (HuR) 
signals. The average OC value (n=10) for HuR and S-HDAg 
is 0.772 (std. deviation= 0,113; n=10) indicating a significant 
colocalization. The results obtained are consistent with the 
hypothesis that HuR and HDAg physically interact in Huh7-
D12 cells. 
 
Fig. (2). In vitro and in vivo interaction of HuR and S-HDAg. 
(A) Overlay of bacterially expressed His6-HuR with recombinant 
S-HDAg. E. coli protein extracts were prepared after induction of 
recombinant protein expression. Increasing amounts of extracts 
containing His6-HuR (lanes 2 to 6), were separated by SDS/PAGE, 
blotted onto nitrocellulose membranes and overlayed with the same 
amount of purified recombinant S-HDAg. Detection of S-HDAg 
was performed with a specific rabbit polyclonal antibody. E. coli 
protein extracts lacking His6-HuR were used as a negative control 
(lane 1). (B) Coimmunoprecipitation of HuR with S-HDAg. Huh7-
D12 cell lysates were immunoprecipitated with an anti-HDAg 
antibody bound to protein G beads. The immunoprecipitates were 
run separated on 12% SDS/PAGE gels and immunoblotted with an 
anti-HuR or anti-HDAg antibody. The negative controls were 
prepared in the absence of the anti-HDAg antibody or using Huh7 
cell protein extracts. 
 Previous reports showed that HDAgs and HDV RNA 
colocalize in the nucleus of human liver cells [38]. Since 
HuR is a RNA binding protein we decided to investigate if 
the distribution pattern of the protein in relation to the virus 
RNA. To do this, a combined in situ hybridization and 
immunofluorescence approach was utilized. A digoxigenin-
labelled probe was used to hybridize with HDV RNAs and 
the HuR protein was detected by immunofluorescence, as  
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above described. Typical examples of the obtained results 
can be observed in Fig. (3D, F). The average OC value 
obtained (0.762; std. deviation = 0.074; n=10), is very 
similar with the one determined for HuR/S-HDAg 
colocalization. Taken together, our results indicate that the 
HuR protein interacts with S-HDAg in human liver cells, and 
additionally suggest that it may also interact with the virus 
RNA. 
HuR Protein is Overexpressed in HDV Expressing Cells 
 It is known that viruses subvert the cellular metabolism 
namely by recruiting host factors to locals of replication in 
the nucleus and by altering gene expression in infected cells. 
Accordingly, it has been previously reported that in human 
hepatoma cells, synthesis of HDV RNA and antigens is 
accompanied by changes in expression levels of several host 
proteins [21, 22] 
 In an attempt to investigate if the synthesis of HDV 
RNPs also induces alterations in the expression levels of the 
HuR protein we decided to compare the relative amounts of 
the protein in Huh7 and Huh7-D12 cells. Protein extracts 
from both cell lines were prepared, separated by SDS-PAGE, 
and analyzed by western blot using an antibody to detect the 
HuR protein. An antibody recognizing the housekeeping 
protein clathrin was used as an internal control in these 
experiments. The blot images were digitalized and band 
intensities were calculated by densitometry using the ImageJ 
program. The obtained results showed that the expression 
levels of HuR were increased 1.7-fold in Huh7-D12 cells 
when compared with Huh7 cells (Fig. 4). Considering that 
only 10-15% of Huh-D12 cells are expressing HDV RNPs at  
 
a given moment [38] this finding may be indicative of a 
possible involvement of the HuR protein in the virus 
replication cycle. 
Silencing of the HuR Protein Results in Decreased 
Expression of HDAgs 
 The HuR protein was previously shown to play an 
important role in mRNA stabilization and control of 
translation (reviewed in [25]). Since we found that HuR 
binds in vivo to S-HDAg, both proteins colocalize in Huh7 
cells, and HuR is overexpressed during synthesis of HDV 
RNPs, we decided to investigate the effect of HuR 
knockdown on HDAg synthesis. 
 To do this we utilized a small hairpin RNA mediated 
knockdown technology based on a pSIREN-RetroQ vector 
coding for a HuR-specific short hairpin RNA (pSIREN-
RetroQ/HuR). Huh7 cells were first transfected with plasmid 
pSVL(D3) in order to produce HDV RNA and antigens, and 
48 hours later transfected again with the pSIREN-RetroQ-
HuR plasmid. Puromycin was added to the medium in order 
to select the pSIREN-RetroQ/HuR transfected cells, and 
protein extracts were prepared. A pSIREN-RetroQ vector, 
targeting the luciferase mRNA (pSIREN-RetroQ/Luc) was 
used in parallel transfections and used as negative control in 
these experiments. The efficiency of reduction of cellular 
HuR protein levels by the shRNAs coded by the pSIREN-
RetroQ/Hur vector was monitored by western blot. As 
shown in Fig. (5), the plasmid-derived expression of shRNA 
against HuR mRNA, reduced the expression of the HuR 
protein by 55% when compared with control pSIREN-
RetroQ/Luc transfected cells. 
 
Fig. (3) Colocalization of HuR with HDV antigens and RNA. (A-C) Double indirect immunofluorescence was used to detect HDAg and 
HuR proteins in cultured Huh7-D12 cells. Cells were fixed with 4% formaldehyde, permeabilized with 0.5% Triton X-100, and stained with 
anti-HDAg antibody (A, green staining) and anti-HuR antibody (B, red staining). In situ hybridization followed by immunofluorescence was 
performed to detect HDV RNA and the HuR protein. After fixation and permeabilization as above, cells were hybridized with a digoxigenin-
labeled probe to detect HDV RNA (D, green staining) and with an anti-HuR antibody (E, red staining). Overlaps of images are shown in 
panels C and F. The JaCoP plugin and ImageJ program were used to determine the Mander´s overlap coefficient. 
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Fig. (4). HuR overexpression in Huh7-D12 cells. (A) Western 
blot analysis of HuR protein in Huh7 and Huh7-D12 cells. Total 
protein extracts were separated by SDS-PAGE, transferred to a 
nitrocellulose membrane, and incubated with anti-HuR and anti-
clathrin antibodies. Images are representative of three independent 
experiments. (B) The blots were digitalized and band intensity was 
calculated using the ImageJ program. Relative expression levels 
were obtained after normalization with the housekeeping clathrin 
protein. 
 We next investigated the effect of HuR silencing in the 
synthesis of delta antigens. This was performed by analyzing 
the relative expression of HDAgs by western blot of protein 
samples obtained from the same knockdown experiment. 
The results are displayed in Fig. (5) and show that 
knockdown of HuR resulted in a decrease of 65% and 93%, 
in S-HDAg and L-HDAg expression levels, respectively. 
These results indicate that HDAg expression is inhibited 
when HuR is silenced in Huh7 cells, suggesting that this 
protein may play an important role in HDV replication. 
DISCUSSION 
 Hepatitis delta virus is the smallest human pathogen 
identified so far being highly dependent on host factors for 
replication and transcription. The HDV RNA genome 
contains a single ORF from which two forms, small and 
large, of a unique protein are derived as a consequence of an 
editing mechanism. Despite its simplicity a limited number 




Fig. (5). Silencing of endogenous HuR reduces expression of 
HDAgs in Huh7-D12 cells. (A) Knockdown of the HuR protein 
was performed using a specific siRNA in Huh7-D12 cells. 48 hrs 
after addition of puromycin, total protein extracts were prepared, 
separated by SDS-PAGE, and transferred to a nitrocellulose 
membrane. Blots were incubated with anti-HuR, anti-clathrin or 
anti-HDAg antibodies, and the displayed images are representative 
of three independent experiments. (B) Images were digitalized and 
band intensity was determined using the ImageJ program. Relative 
expression levels were obtained after normalization with the 
housekeeping protein clathrin. Inhibition of HDAg expression is 
presented as a percentage after comparison with the values obtained 
with the negative control vector pSIREN-RetroQ/Luc provided by 
the manufaturer. 
proteins that interact with HDV RNA or antigens to 
modulate replication and pathogenesis. Among them are 
RNA polymerases I, II, and III, the small form of adenosine 
deaminase (ADAR 1), hnRNP-L, ASF/SF2, p54 (nrb), 
GADPH, eEF1A1, NELF, PSF, PKR, nucleolin, and DIPA 
(reviewed in [12]). Recently, using a combined proteomic-
RNAi screen of potential host factors involved in HDV 
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replication it was possible to identify over 100 proteins 
capable of binding to FLAG-S-HDAg [23]. 
 In this work, we used a yeast two-hybrid approach to 
identify human liver proteins capable of interacting with S-
HDAg. We initially obtained 112 positive clones of which 31 
were found to contain DNA sequences encoding for known 
proteins in a database (Genbank). One of these sequences was 
found to code for the HuR protein, a member of the ELAV 
family of RNA binding proteins. Subsequently, this sequence 
was subcloned in a prokaryotic expression vector (pET28c) and 
the corresponding protein was produced in E. coli as a fusion 
with His-tag. HuR is a nucleocyto-plasmic shuttling protein 
previously shown to be involved in mRNA stabilization. It is 
well established that HuR, which is ubiquously expressed in 
proliferating cells, and selectively binds AU-rich elements 
(AREs) in the 3’ untranslated region of mRNAs. Binding of 
HuR to mRNAs is believed to antagonize the mRNA 
degradation pathway signaled by AREs. The Herpesvirus 
saimiri small nuclear RNAs contain an ARE sequence which 
was found to be able to recruit HuR [42]. Furthermore, HuR 
was reported to modulate translation of HIV-1 and HCV IRES 
elements acting as a repressor or activator, respectively [33]. 
This regulation does not require direct binding of HuR to IRES. 
 This prompted us to investigate a possible involvement 
of HuR in HDV replication. Our first approach was directed 
to confirm the detected HuR-S-HDAg interaction observed 
in the yeast two-hybrid screening. Initially, this was 
performed using a blot overlay assay with purified S-HDAg 
and increasing amounts of HuR protein present in E. coli cell 
extracts. The results obtained with this assay indicated that 
HuR and S-HDAg specifically interact in vitro. Finally, we 
decided to investigate if the two proteins interact in vivo in 
human liver cells. A coimmunoprecipitation assay using a 
specific polyclonal antibody against HDAg was performed 
allowing confirming the previously observed interactions. 
 It is known that viruses subvert the nuclear organization 
and can recruit components of the host cell machinery to 
sites of replication and transcription (for a review see [44]). 
In the particular case of HDV, a previous work showed that 
both delta antigens and RNA are mainly localized in the 
nucleus of infected cells displaying, in most cases, a diffuse 
nucleoplasmic distribution with additional accumulation in 
foci [38]. As shown by the authors, these foci although 
containing virus RNA and antigens, do not represent 
preferential sites of HDV replication and transcription. 
However, if HuR is involved in HDV replication one would 
expect to observe a colocalization of this protein with HDV 
components in the nucleus. This hypothesis was tested by 
immunofluorescence and in situ hybridization in Huh7-D12 
cells, and HDV cDNA stably transfected human hepatoma 
cell line which constitutively expresses both virus RNA and 
antigens [35, 38]. After confocal microscopy followed by 
image analysis to calculate the Mander’s overlap coefficient, 
it was found that over 75% of endogenous HuR protein 
colocalizes with both virus RNA and antigens indicating that 
HuR may play a role in the HDV life cycle. 
 Previous proteomic analysis of Huh7 cells stably 
expressing HDV RNPs or transiently expressing each of the 
HDV components separately, allowed identifying several 
host proteins displaying altered expression patterns [21, 22]. 
Although the authors did not address possible interactions 
with host proteins, more recently it was reported that two of 
the differentially expressed proteins in S-HDAg transfected 
Huh7 cells, hnRNP D and ZNF326, interact with S-HDAg 
[23]. In an attempt to investigate if the HuR protein is also 
differentially expressed in cells expressing HDV 
components, we compared the relative amounts of this 
protein in Huh7 and Huh7-D12 cells. Western blots were 
performed in order to detect HuR followed by determination 
of band intensity. The results were normalized using an 
antibody against the housekeeping protein clathrin. We 
found that HuR is 1.7 times more abundant in HDV 
expressing Huh7-D12 cells when compared to Huh7 cells. 
As reported before, only a limited amount, 10%-15% of 
Huh7-D12 cells express HDV RNPs at a given moment in 
time [38]. Accordingly, the relative expression values of 
HuR in this cell line may be indicative of a significant 
upregulation in the presence of HDV. 
 Silencing of HuR with a specific siRNA resulted in 
marked decrease of both S-HDAg and L-HDAg expression 
suggesting a possible role in HDV replication. However, the 
mechanism(s) by which HuR influences the expression of 
delta antigens remain to be elucidated. Since HDV mRNAs 
are capped and polyadenylated [45] it is unlikely that HuR 
participates in their stabilization by binding to AREs. It is, 
thus, possible to speculate that the effect of HuR silencing on 
HDAg expression may be due to an impaired stabilization of 
cellular mRNAs with consequent decrease in production of 
host proteins necessary for HDV replication. This may be 
supported by reports showing that HuR stabilizes ARE-
containing mRNAs [46] namely in response to stress induced 
by heat-shock, UV light and infection [47]. Alternatively, 
HuR could contribute to the stabilizion of genomic and/or 
antigenomic HDV RNAs during replication and transcript-
ion. 
 The mechanisms by which HuR promotes mRNA stabi-
lity were previously addressed allowing the identification of 
four protein ligands in coimmunoprecipitation assays: SET , 
SET , pp32, and APRIL [46]. Binding of these ligands to 
HuR is thought to increase HuR affinity for mRNAs or 
modulate its intracellular localization. Since HuR function is 
altered depending on the bound protein ligand it is 
temptative to suggest that the interaction between S-HDAg 
and HuR may also influence the activity of the protein(s) 
modulating HDV replication. In accordance with this view, 
HuR was also found to interact with the HIV-1 reverse 
transcriptase, modulating the activity of the enzyme, in a 
mechanism independent of binding of HuR to the virus RNA 
[30]. Several functions have been assigned to the S-HDAg in 
virus replication cycle: stabilization of the genome and 
antigenome [23, 48], protection of HDV RNAs against 
editing [49], transport of the virus genome to the nucleus 
[50], acceleration of ribozyme activities [51, 52], and 
improvement of processivity during RNA-directed RNA 
transcription [10]. Whether binding of HuR affects, 
positively or negatively, any of the S-HDAg functions 
remains to be clarified and clearly needs to be addressed in 
the future. 
CONCLUSION 
 In conclusion, we report that HuR and S-HDAg interact 
both in vitro and in vivo and colocalize in human liver cells. 
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Furthermore, HuR silencing with specific siRNAs leads to a 
decrease in both S-HDAg and L-HDAg expression. The 
obtained results suggest that HuR may play an important role 
in HDV replication. 
ACKNOWLEDGMENTS 
 We are grateful to Dr. John Taylor (Fox Chase Cancer 
Center, USA) for the generous gift of plasmid pSVL(D3) 
used in this work. We acknowledge Dr. José Rino (Institute 
of Molecular Medicine, Lisbon) for help with the confocal 
microscope. This work was supported by Fundação para a 
Ciência e Tecnologia (PTDC/SAU-MII/098314/2008). AC is 
a recipient of a FCT PhD grant. 
REFERENCES 
[1] Govindarajan S, Chin KP, Redeker AG, Peters RL. Fulminant B 
viral hepatitis: Role of delta agent. Gastroenterology 1984; 6: 1417-
20. 
[2] Rizzetto M, Hoyer B, Canese MG, Shih JW, Purcell RH, Gerin JL. 
Delta agent: association of delta antigen with hepatitis B surface 
antigen and RNA in serum of delta-infected chimpanzees. Proc 
Natl Acad Sci USA 1980; 77: 6124-8. 
[3] Bonino F, Heermann KH, Rizzetto M, Gerlich WH. Hepatitis delta 
virus: Protein vomposition of velta antigen and its hepatitis B virus-
derived envelope. J Virol 1986; 58: 945-50. 
[4] Smedile A, Rizzetto M, Gerin J. Advances in hepatitis D virus 
biology and disease. Prog Liver Dis 1994; 12: 157-75. 
[5] Casey JL, Gerin JL. Hepatitis D virus RNA editing: Specific 
modification at adenosine in the antigenome RNA. J Virol 1995; 
69: 7593-600. 
[6] Lin JH, Chang MF, Baker SC, Govindarajan S, Lai MMC. 
Characterization of hepatitis delta virus antigen. J Virol 1990, 64: 
4051-8. 
[7] Lazinski DW, Taylor JM. Relating structure to function in the 
hepatitis delta virus antigen. J Virol 1993; 67: 2677-80. 
[8] Alves C, Freitas N, Cunha C. Characterization of the nuclear 
localization signal of the hepatitis delta virus antigen. Virology 
2008; 370: 12-21. 
[9] Glenn JS, Watson JA, Havel CM, White JO. Identification of a 
prenylation site in the delta virus large antigen. Science 1992; 256: 
1331-3. 
[10] Yamaguchi Y, Filipovska J, Yano K, et al. Stimulation of RNA 
polymerase II elongation by hepatitis delta antigen. Science 2001; 
293: 124-7. 
[11] Chang FL, Chen PJ, Tu SJ, Wang CJ, Chen DS. The large form of 
hepatitis antigen is crucial for assembly of hepatitis virus. Proc Natl 
Acad Sci 1991; 88: 8490-4. 
[12] Greco-Stewart VS, Pelchat M. Interaction of Host Cellular proteins 
with components of the Hepatitis Delta virus. Viruses 2010; 2: 189-
212. 
[13] Wong SK, Lazinski DW. Replicating hepatitis delta virus RNA is 
edited in the nucleus by the small form of ADAR1. Proc Natl Acad 
Sci USA 2002; 99: 15118-23. 
[14] Yamaguchi Y, Mura T, Chanarat S, Okamoto S, Handa H. 
Hepatitis delta antigen binds to the clamp of RNA polymerase II 
and affects transcriptional fidelity. Genes Cells 2007; 12: 863-75. 
[15] Abrahem A, Pelchat M. Formation of an RNA polymerase II 
preinitiation complex on an RNA promoter derived from the 
hepatitis delta virus RNA genome. Nucleic Acids Res 2008; 36: 
5201-11. 
[16] Huang WH, Mai RT, Lee YH. The transcription factor YY1 and its 
associated acetyltranspherases CBP and p300 interact with hepatitis 
delta virus antigens and modulate the hepatitis delta virus RNA 
replication. J Virol 2008; 82: 7313-24. 
[17] Greco-Stewart VS, Thibault CS, Pelchat M. Binding of the 
polypirimidine tract-binding protein-associated splicing factor 
(PSF) to the hepatitis delta virus RNA. Virology 2006; 356: 35-44. 
[18] Lee CH, Chang SC, Chen CJ, Chang MF. The nucleolin binding 
activity of hepatitis delta antigen is associated with nucleolus 
targeting. J Biol Chem 1998; 273: 7650-6. 
[19] Huang WH, Yung BY, Syu WJ, Lee YH. The nucleolar 
phosphoprotein B23 interacts with hepatitis delta antigens and 
modulates hepatitis delta virus RNA replication. J Biol Chem 2001; 
276: 25166-75. 
[20] Wang YH, Chang SC, Huang C, Li YP, Lee CH, Chang MF. Novel 
nuclear export signal-interacting protein, NESI, critical for the 
assembly of hepatitis delta virus. J Virol 2005; 79: 8113-20. 
[21] Mota S, Mendes M, Penque D, Coelho AV, Cunha C. Changes in 
the proteome of Huh7 cells induced by transient expression of 
hepatitis D virus RNA and antigens. J Proteomics 2008; 71: 71-9. 
[22] Mota S, Mendes M, Freitas N, Penque D, Coelho AV, Cunha C. 
Proteome analysis of a human liver carcinoma cell line stably 
expressing hepatitis delta vírus ribonucleoproteins. J Proteomics 
2009; 72: 616-27. 
[23] Cao D, Haussecker D, Huang Y, Kay MA. Combined proteomic-
RNAi screen for host factors involved in human hepatitis delta 
virus replication. RNA 2009; 15: 1971-9. 
[24] Fan XC, Steitz J. HNS, a nuclear-cytoplasmic shuttling sequence in 
HuR. Proc Natl Acad Sci USA 1998, 95: 15293-8. 
[25] Brennan CM, Steitz JA. HuR and mRNA stability. Cell Mol Life 
Sci 2001; 58: 266-77. 
[26] Lal A, Kawai T, Yang X, Mazan-Mamczarz K, Gorospe M. 
Antiapoptotic function of RNA-binding protein HuR effected 
through prothymosin alpha. EMBO J. 2005; 24: 1852-62. 
[27] Mazroui R, Di Marco S, Clair E, et al. Caspase-mediated cleavage 
of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of 
apoptosis. J Cell Biol 2008; 180: 113 - 27. 
[28] Lopez de Silanes I, Lal A, Gorospe M. HuR: posttranscriptional 
paths to malignancy. RNA Biol 2005; 2: 11-3. 
[29] Gorospe M. HuR in the mammalian genotoxic response: post-
transcriptional multitasking. Cell Cycle 2003; 2: 412-4. 
[30] Lemay J, Mandou-Peindara P, Bader T, et al. HuR interacts with 
human immunodeficiency virus type I reverse transcriptase, and 
modulates reverse transcription in infected cells. Retrovirology 
2008; 5: 47. 
[31] Spangberg K, Wiklund L, Schwartz S. HuR, a protein implicated in 
oncogene and growth factor mRNA decay, binds to the 3’ ends of 
hepatitis C virus RNA of both polarities. Virology 2000; 274: 378-
90. 
[32] Sokolowski M, Furneaux H, Schwartz S. The inhibitory activity of 
the AU-rich RNA element in the human papillomavirus type 1 late 
3' untranslated region correlates with its affinity for the elav-like 
HuR protein. J Virol 1999; 73: 1080-91. 
[33] Rivas-Aravena A, Ramdohr P, Vallejos M, et al. The ELAV-like 
protein HuR exerts translational control of viral internal ribosome 
entry sites. Virology 2009; 392: 178-85. 
[34] Tavanez JP, Cunha C, Silva MC, David E, Monjardino J, Carmo-
Fonseca M. Hepatitis delta virus ribonucleoproteins shuttle 
between the nucleus and the cytoplasm. RNA 2002, 8: 637-46. 
[35] Cheng D, Yang A, Thomas H, Monjardino J. Characterization of 
stable hepatitis delta-expressing cell lines: Effect of HDAg on cell 
growth. Prog Clin Biol Res 1993; 382: 149-53. 
[36] Browne GJ, Fardilha M, Oxnham SK, et al. Sarp, a new 
alternatively spliced protein phosphatase 1 and DNA interacting 
protein. Biochem J 2007; 402: 187-96. 
[37] Saldanha J, Homer E, Goldin P, Thomas HC, Monjardino J. 
Cloning and expression of an immunodominant region of the 
hepatitis delta antigen. J Gen Virol 1990; 71: 471-5. 
[38] Cunha C, Monjardino J, Chang D, Krause S, Carmo-Fonseca M. 
Localization of hepatitis delta virus in the nucleus of human cells. 
RNA 1998; 4: 680-93. 
[39] Kuo MYP, Chao M, Taylor J. Initiation of replication of the human 
hepatitis delta virus genome from cloned DNA: Role of delta 
antigen. J Virol 1989; 63: 1945-50. 
[40] Bolte S, Cordelieres FP. A guided tour into subcellular 
colocalization analysis in light microscopy. J Microsc 2006; 224: 
213-32. 
[41] Manders E, Stap J, Brakenhoff G, van Driel R, Aten J. Dynamivs 
of three dimensional replication patterns during the S-phase, 
analysed by double labelling of DNA and confocal microscopy. J 
Cell Sci 1992; 103: 857-62. 
[42] Cook HL, Mischo HE, Steitz JA. The Herpesvirus saimiri small 
nuclear RNAs recruit AU-rich element-containing mRNA levels in 
virally transformed T cells. Mol Cell Biol 2004; 24: 4522-33. 
[43] Ma WJ, Cheng S, Campbell C, Wrigth A, Furneaux H. Cloning and 
characterization of HuR, a ubiquitously expressed Elav-like 
protein. J Biol Chem 1996; 271: 8144-51. 
In Vivo Interaction of the Hepatitis Delta Virus Small Antigen The Open Virology Journal, 2011, Volume 5    21 
[44] Ahlquist P, Noueiry AO, Lee W-M, Kushner DB, Dye BT. Host 
Factors in Positive-Strand RNA Virus Genome Replication. J Virol 
2003; 77: 8181-6. 
[45] Gudima S, Dingle K, Wu TT, Moraleda G, Taylor J. 
Characterization of the 5’ ends for polyadenilated RNAs 
synthesized during replication of hepatitis delta virus. J Virol 1999; 
73: 6533-9. 
[46] Brennan CM, Gallouzi I-E, Steitz JA. Protein ligands to HuR 
modulate its interaction with targets mRNAs in vivo. J Cell Biol 
2000, 151: 1-14. 
[47] Wang W, Furneaux H, Cheng H, et al. HuR regulates p21 mRNA 
stabilization by UV light. Mol. Cell Biol 2000, 20: 760-9. 
[48] Lazinski DW, Taylor JM. Intracellular cleavage and ligation of 
hepatitis delta virus genomic RNA: Regulation of ribozyme activity 
by cis-acting sequences and host factors. J Virol 1995; 69: 1190-
200. 
[49] Cheng Q, Jayan GC, Casey JL. Differential inhibition of RNA 
editing in hepatitis delta virus genotype III by the short and long 
forms of hepatitis delta antigen. J Virol 2003; 77: 7786-95. 
[50] Xia YP, Yeh CT, Ou JH, Lai MMC. Characterization of nuclear 
targeting signal of hepatitis delta antigen: nuclear transport as a 
protein complex. J Virol 1992; 66: 914-21. 
[51] Huang ZS, Wu HN. Identification and characterization of the RNA 
chaperone activity of hepatitis delta antigen peptides. J Biol Chem 
1998; 273: 26455-61. 
[52] Jeng KS, Su PY, Lai MM. Hepatitis delta antigens enhance the 
ribozyme activities of hepatitis delta virus RNA in vivo. J Virol 
1996; 70 : 4205-9. 
 
 
Received: July 30, 2010 Revised: October 27, 2010 Accepted: November 4, 2010 
 
© Casaca et al.; Licensee Bentham Open. 
 
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.org/licenses/by-nc/ 
3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. 
 
 
 
 
